# Creatine Supplements May Help Treat Depression, Early Evidence Shows

Creatine, a compound long associated with athletic performance and muscle building, shows early promise as a treatment for depression. Recent research suggests the supplement may boost brain energy metabolism in ways that reduce depressive symptoms, particularly in women.

The brain relies heavily on adenosine triphosphate (ATP), a molecule that powers cellular function. Creatine increases ATP availability in the brain, fueling neural processes tied to mood regulation. This mechanism differs from how antidepressants typically work, opening a potential new avenue for people who don't respond to conventional medications.

Several clinical trials have examined creatine's antidepressant effects. A 2012 study published in the Journal of Affective Disorders found that women taking 5 grams of creatine daily alongside standard antidepressants showed greater symptom improvement than those on medication alone. Another trial demonstrated that creatine reduced depression scores in adolescents within weeks of starting supplementation.

The evidence remains preliminary. Most studies involve small sample sizes, and researchers have not yet determined optimal dosing or identified which patients benefit most. Depression varies widely between individuals, and a supplement effective for some may not help others. Scientists also need longer-term safety data to understand whether creatine poses risks with extended use.

Creatine does appear safe for short-term use in healthy adults. The supplement is naturally produced in the body and found in foods like red meat and fish. Side effects are typically mild, though some people report muscle cramps or digestive upset.

Anyone considering creatine for depression should discuss it with their doctor first. The supplement works best alongside established treatments, not as a replacement. Antidepressant medications and therapy remain first-line approaches. Creatine might eventually become a complementary tool for treatment-resistant depression